Works matching IS 22351795 AND DT 2021 AND VI 10 AND IP 2

Results: 9

Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective Study.

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 107, doi. 10.1159/000512781

By:

Changhoon Yoo;
Jwa Hoon Kim;
Min-Hee Ryu;
Sook Ryun Park;
Danbi Lee;
Kang Mo Kim;
Ju Hyun Shim;
Young-Suk Lim;
Han Chu Lee;
Joycelyn Lee;
David Tai;
Lam Chan, Stephen;
Baek-Yeol Ryoo

Publication type:

Article

Sequential Therapy for Hepatocellular Carcinoma after Failure of Atezolizumab plus Bevacizumab Combination Therapy.

Published in:

2021

By:

Masatoshi Kudo

Publication type:

Editorial

Reply to the Letter "Comment on Regarding Manuscript 'Treatment of Intermediate Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies'".

Published in:

2021

By:

Kazuhiro Nouso;
Kazuya Kariyama

Publication type:

Letter to the Editor

Comment on the Manuscript "Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies".

Published in:

2021

By:

Zhaonan Li;
Dechao Jiao;
Xinwei Han

Publication type:

Letter to the Editor

Hepatic Arterial Infusion Chemotherapy Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombosis of the Main Trunk or Bilobar of the Portal Vein.

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 151, doi. 10.1159/000513706

By:

Yumi Kosaka;
Tomoki Kimura;
Tomokazu Kawaoka;
Yutaro Ogawa;
Kei Amioka;
Kensuke Naruto;
Yuki Yoshikawa;
Chihiro Kikukawa;
Yosuke Suehiro;
Kenji Yamaoka;
Yuwa Ando;
Shinsuke Uchikawa;
Kei Morio;
Takashi Nakahara;
Eisuke Murakami;
Shoichi Takahashi;
Masataka Tsuge;
Akira Hiramatsu;
Michio Imamura;
Keigo Chosa

Publication type:

Article

MRI Features for Predicting Microvascular Invasion of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 94, doi. 10.1159/000513704

By:

Seung Baek Hong;
Sang Hyun Choi;
So Yeon Kim;
Ju Hyun Shim;
Seung Soo Lee;
Jae Ho Byun;
Seong Ho Park;
Kyung Won Kim;
Suk Kim;
Nam Kyung Lee

Publication type:

Article

Evolutions in the Management of Hepatocellular Carcinoma over Last 4 Decades: An Analysis from the 100 Most Influential Articles in the Field.

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 137, doi. 10.1159/000513412

By:

Gang Xu;
Bao Jin;
Xiaomeng Xian;
Huayu Yang;
Haitao Zhao;
Shunda Du;
Masatoshi Makuuchi;
Pawlik, Timothy M.;
Yilei Mao

Publication type:

Article

Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 126, doi. 10.1159/000513404

By:

Campani, Claudia;
Vitale, Alessandro;
Dragoni, Gabriele;
Arena, Umberto;
Laffi, Giacomo;
Cillo, Umberto;
Giannini, Edoardo G.;
Tovoli, Francesco;
Rapaccini, Gian Ludovico;
Di Marco, Maria;
Caturelli, Eugenio;
Zoli, Marco;
Sacco, Rodolfo;
Cabibbo, Giuseppe;
Mega, Andrea;
Guarino, Maria;
Gasbarrini, Antonio;
Svegliati-Baroni, Gianluca;
Foschi, Francesco Giuseppe;
Biasini, Elisabetta

Publication type:

Article

What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355

By:

Atsushi Hiraoka;
Takashi Kumada;
Toshifumi Tada;
Kazuya Kariyama;
Joji Tani;
Shinya Fukunishi;
Masanori Atsukawa;
Masashi Hirooka;
Kunihiko Tsuji;
Toru Ishikawa;
Koichi Takaguchi;
Ei Itobayashi;
Kazuto Tajiri;
Noritomo Shimada;
Hiroshi Shibata;
Hironori Ochi;
Kazuhito Kawata;
Satoshi Yasuda;
Hidenori Toyoda;
Hideko Ohama

Publication type:

Article